HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France
Infection 2024

Ihtisham Ul Haq

Speaker at Infection Conferences - Ihtisham Ul Haq
Federal University of Minas Gerais, Brazil
Title : Antimicrobial activity of peptides derived from lycosa erythrognatha spider venom against quinolone-resistant uropathogenic escherichia coli (UPECs)


Uropathogenic Escherichia coli (UPECs) is the leading pathogen involved in urinary tract infection. Although quinolones are widely used in these cases, the resistance of UPECs to this class has been growing significantly, challenging the effectiveness of antibacterial therapy. Thus, the development of novel antimicrobials agents for the treatment of quinolone-resistant UPECs infections is imperative. Herein, arthropod toxin stand out as a promising source of new bioactive compounds against superbugs such as quinolone-resistant UPECs, especially antimicrobial peptides (AMPs).

Objectives: To study the antibacterial effect of synthetic peptides derived from a natural compound present in the venom of the spider Lycosa erythrognatha against clinical isolates of quinolone-resistant UPECs.

Methodology: Ten clinical isolates of UPECs were included. The bacteria were identified by biochemical-physiological assay. Antimicrobial resistance profile and the extended spectrum beta-lactamase (ESBL) production was determined. Next, the antibacterial effect of the peptides was studied by determining the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). In silico study was performed to determine the mode of action of the peptide against the E. coli adhesins PapG and FimH via ClusPro webserver.

Results: Five compounds were tested, but LyeTx I mnΔK (16 amino acid residues; 1871.32 Da) showed the best activity. The MIC and MBC of this compound was of 2 µM and 8 µM, respectively, to all included isolates. All the isolates were resistant to nalidixic acid, ofloxacin, norfloxacin ciprofloxacin and levofloxacin. In addition, five isolates were ESBL-positive. Peptide showed binding with both of the adhesins, PapG and FimH, that help E. coli in binding to kidney and bladder cells, respectively.

Conclusion: The LyeTx I mnΔK peptide is a potential prototype to development of new antimicrobial agents against quinolone-resistant uropathogenic Escherichia coli.


Mr. Ihtisham Ul Haq is pursuing Joint PhD at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil and Silesian University of Technology, Gliwice, Poland. He is working under the supervision of Prof Maria Elena de Lima and Prof katarzyna Krukiewicz. His main research interests are antimicrobials and antimicrobials peptides. He has 22 publications including 7 book chapters 4 research papers and 11 review papers